ISO 10993-1:2018
Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process

Standard No.
ISO 10993-1:2018
Release Date
2018
Published By
International Organization for Standardization (ISO)
Latest
ISO 10993-1:2018

ISO 10993-1:2018 Referenced Document

  • ISO 10993-10:2010 Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization
  • ISO 10993-11:2017 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • ISO 10993-12:2012 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
  • ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • ISO 10993-14:2001 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics
  • ISO 10993-15:2000 Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys
  • ISO 10993-16:2017 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables
  • ISO 10993-17:2002 Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances
  • ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • ISO 10993-2:2006 Biological evaluation of medical devices - Part 2: Animal welfare requirements
  • ISO 10993-3:2014 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • ISO 10993-4:2017 Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood
  • ISO 10993-5:2009 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
  • ISO 10993-6:2016 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • ISO 10993-7:2008 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • ISO 10993-9:2009 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products
  • ISO 14971:2007 Medical devices - Application of risk management to medical devices
  • ISO/TS 10993-20:2006 Biological evaluation of medical devices - Part 20: Principles and methods for immunotoxicology testing of medical devices

ISO 10993-1:2018 history

  • 2018 ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • 2010 ISO 10993-1:2009/Cor 11:2010 Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
  • 2010 ISO 10993-1:2009/cor 1:2010 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process; Technical Corrigendum 1
  • 2009 ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • 2003 ISO 10993-1:2003 Biological evaluation of medical devices - Part 1: Evaluation and testing
  • 1997 ISO 10993-1:1997 Biological evaluation of medical devices - Part 1: Evaluation and testing
  • 1992 ISO 10993-1:1992/Cor 1:1992 Biological evaluation of medical devices; part 1: guidance on selection of tests; technical corrigendum 1
  • 1992 ISO 10993-1:1992 Biological evaluation of medical devices; part 1: guidance on selection of tests
Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process



Copyright ©2023 All Rights Reserved